Strep | Flu | Covid | RSV
Developed to be the first FDA approved rapid at-home test for Strep A*
Patient friendly - No swab, Gargle Test
Designed to provide higher real-world reliability
* Pending FDA approval
Up to 70% of patients receive antibiotic therapy while only 20 - 30% have Strep A
Proprietary Disposable Home Reader
-
Standardizes image capture conditions
-
Identifies positive test result from faint lines
-
Optimizes communication with telehealth provider
Return cartridge to original packaging
Place phone on box
Served as CEO of Green Smoke through its product launch, rapid market growth, and acquisition by Altria for $130 M. MBA from Tel Aviv University and Kellogg School of Management of Northwestern University.
Robert Levitz, MBA
CEO & Co-Founder
Pediatric infectious disease clinician with a PhD in microbiology from NYU and an MD from the University of Miami. Previous positions include SVP for Global Regulatory Affairs at Medtronic and Director of the Office of Device Evaluation at the FDA.
Susan Alpert, PhD, MD
Sr. Regulatory Advisor
Practicing pediatrician board certified in pediatrics, allergy, and clinical immunology in the United States and Israel. Completed fellowship at Boston’s Children’s Hospital and MD from Albert Einstein College of Medicine.
Lazar Fruchter, MD
CMO & Co-Founder
Hero Scientific Team
Over a decade experience developing innovative products and strategic partnerships that address the needs of key stakeholders in the US and global healthcare market. Studied finance and biochemistry at Miami University of Ohio.
Ilya Budik
VP Business Development
Previously conducted research at Columbia University Department of Genetics. Completing MS in biotechnology at Johns Hopkins University.
Leah Forgosh
Sr. Biologist
Over 25 years experience in mechanical engineering. BS in mechanical engineering from the Technion Israel Institute of Technology.
Arie Holtz
Lead Engineer & Co-Founder
Over 40 years of laboratory research experience in academia and industry including at Hebrew University and the Weizmann Institute.
Boaz Arieli, PhD
Sr. Microbiologist
Over 35 years experience in the field of device design, rapid prototyping, and automation. Responsible for all areas of development from industrial design through production. Holds patents in fields including optics, diagnostics, and mechanics.
Tzvi Feldman
VP Device
Specialist in otolaryngology and head and neck surgery. MD from McMaster University in Canada. Completed specialty training at Hebrew University and sub-specialty training at UCSD California.
Jay Wohlgelernter, MD
Principal Investigator
Over a decade experience in managing clinical trials for innovative pharma, medical device, and medical cannabis companies. Holds an MS in biotechnology from Bar Ilan University.
Donna Donin Ehrenberg
Clinical Trial Specialist
A veteran data analyst with extensive experience in business strategy. Previously head of finance, strategy, and analytics at Altria Israel. Holds a BA in Economics from the Technion Israel Institute of Technology and an MBA from Tel Aviv University.
Tsahi Schlinger, MBA
Business Analyst
Clinical pediatrician with 20 years experience including with Leumit Health Services in Israel. Involved in medical research of innovative and non-invasive strep detection methods. Completed MD from University of Pennsylvania and pediatric specialization at Harvard Medical School's Children's Hospital in Boston.
Efraim Rosenbaum, MD
Clinical Pediatrician
Over 40 years’ experience in development of rapid, point of care medical diagnostic devices for infectious diseases.
Co-founder and CTO of Orgenics (acquired by Alere).
Serves as industrial diagnostics R&D adviser to various organizations.
Falk Fish, PhD
IVD R&D Advisor
Yair Bloch
Regulatory & Reimbursement Manager
